Comparative Pharmacology
Head-to-head clinical analysis: SULFAIR 10 versus SULFAIR 15.
Peer-Reviewed Evidence
Head-to-head clinical analysis: SULFAIR 10 versus SULFAIR 15.
SULFAIR 10 vs SULFAIR-15
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Bacteriostatic inhibitor of dihydropteroate synthase, blocking folic acid synthesis in susceptible bacteria.
Sulfadoxine is a long-acting sulfonamide that inhibits dihydropteroate synthase, blocking folate synthesis. Pyrimethamine inhibits dihydrofolate reductase, synergistically inhibiting nucleic acid synthesis in Plasmodium species.
5 mg orally once daily, taken at bedtime.
15 mg orally every 6 hours, not to exceed 60 mg/day.
None Documented
None Documented
Terminal elimination half-life of 8-12 hours in adults with normal renal function (CrCl >60 mL/min); extends to 20-30 hours in severe renal impairment (CrCl <30 mL/min), requiring dose adjustment.
12–15 hours in healthy adults; prolonged to 20–30 hours in moderate hepatic impairment.
Renal excretion of unchanged drug (approximately 70-80%) and hepatic metabolism (20-30% as metabolites). Fecal elimination is minimal (<5%).
Renal excretion unchanged: 70%; hepatic metabolism to inactive metabolites: 20%; fecal excretion: 10%.
Category C
Category C
Antibiotic (Sulfonamide)
Antibiotic (Sulfonamide)